Flerie Invest AB Stock

Equities

FLERIE

SE0008966295

Pharmaceuticals

Delayed Nasdaq Stockholm 11:01:57 2024-07-03 am EDT 5-day change 1st Jan Change
0.467 SEK -1.48% Intraday chart for Flerie Invest AB -2.71% +85.16%
Dynamic Chart
1 day+1.94%
1 week-2.07%
Current month+0.42%
More quotes
1 week
0.46
Extreme 0.461
0.49
1 month
0.46
Extreme 0.461
0.57
Current year
0.46
Extreme 0.461
0.57
1 year
0.46
Extreme 0.461
0.57
3 years
0.46
Extreme 0.461
0.57
5 years
0.46
Extreme 0.461
0.57
10 years
0.46
Extreme 0.461
0.57
More quotes
Date Price Change Volume
24-07-03 0.467 -1.48% 2 229 295
24-07-02 0.474 +1.94% 1,776,344
24-07-01 0.465 -1.48% 2,922,379
24-06-28 0.472 -1.67% 10,759,850
24-06-27 0.48 0.00% 9,399,819

Delayed Quote Nasdaq Stockholm, July 02, 2024 at 12:00 pm EDT

More quotes
Flerie AB, formerly InDex Pharmaceuticals Holding AB, is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is an active long-term global biotech and pharmaceutical investor that managing a portfolio of companies in Europe, Israel, and the US. Flerie invests in companies across the entire value chain, providing exposure to opportunities across three segments: Product Development, Commercial Growth, and Limited Partnerships. The Product Development segment consists of early-stage biotech and pharma companies in product development. The Commercial Growth segment consists of companies that are already selling products or services and showcasing proof-of-concept with high growth and some that have already reached profitability. The Limited Partnerships segment provides benefits for the other two segments, including co-investment opportunities, and derisks Flerie’s investment portfolio.
More about the company
  1. Stock Market
  2. Equities
  3. FLERIE Stock